Shoulder Innovations raises FY25 revenue view to $45M-$46M from $42M-$44M

Consensus is for FY25 revenue $43.18M. Rob Ball, CEO of Shoulder Innovations (SI), said, “Looking ahead, we see substantial opportunities for further growth within our addressable $2.8B global market opportunity. Shoulder Innovations’ disruptive ecosystem of products, digital solutions, and differentiated commercial model, backed by strong clinical results and proprietary business intelligence capabilities, is addressing the challenges of shoulder arthroplasty. As we execute on commercial expansion, these strengths position us well to capture additional share, particularly as shoulder surgical care continues to grow in the outpatient setting.”